Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 8, 2006, Pages 1071-1077

  Baum, Bruce J ^a   Zheng, Changyu ^a   Cotrim, Ana P ^a   Goldsmith, Corinne M ^a   Atkinson, Jane C ^b   Brahim, Jaime S ^b   Chiorini, John A ^a   Voutetakis, Antonis ^a   Leakan, Rose Anne ^c   Van Waes, Carter ^d   Mitchell, James B ^e   Delporte, Christine ^f   Wang, Songlin ^g   Kaminsky, Stephen M ^h   Illei, Gabor G ^a  

^a Gene Therapy and Therapeutics Branch   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c CLINICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^g Faculty of Stomatology   (China)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adenoviral vector; Animal model; Aquaporin 1; Clinical trial; Gene therapy; Radiation damage; Salivary gland

Indexed keywords

ADENOVIRUS VECTOR; AQUAPORIN 1; COMPLEMENTARY DNA;

CLINICAL CHEMISTRY; DNA TRANSFER; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL RAT; GENE TARGETING; HEAD CANCER; HEMATOLOGY; HUMAN; HYPOSALIVATION; IONIZING RADIATION; MINIPIG; MORBIDITY; NECK CANCER; NONHUMAN; PAROTID GLAND; PAROTID GLAND DISEASE; PRIORITY JOURNAL; RADIATION FIELD; RADIATION INJURY; REVIEW; SALIVARY GLAND; SALIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; AQUAPORIN 1; DNA, COMPLEMENTARY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; PAROTID GLAND; RADIATION INJURIES, EXPERIMENTAL; RATS; SALIVARY GLAND DISEASES; SALIVARY GLANDS; SWINE; SWINE, MINIATURE;

ANIMALIA; SUS SCROFA;

EID: 33748568793     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.11.006     Document Type: Review

References (42)

1. Oral cancer facts - http://www.oralcancerfoundation.org/.
2. G.L. Day, Cancer Rates and Risks - NIH; NCI - online publication- From the Epidemiology and Extramural Programs Branch, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland -http://seer.cancer.gov/publications/raterisk/risks175.html.
3. Bjordal K., Ahlner-Elmqvist M., Hammerlid E., Boysen M., Evensen J.F., Bjorklund A., Jannert M., Westin T., and Kaasa S. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope 111 (2001) 1440-1452
4. Terrell J.E., Ronis D.L., Fowler K.E., Bradford C.R., Chepeha D.B., Prince M.E., Teknos T.N., Wolf G.T., and Duffy S.A. Clinical predictors of quality of life in patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130 (2004) 401-408
5. Anscher M.S., Chen L., Rabbani Z., Kang S., Larrier N., Huang H., Samulski T.V., Dewhirst M.W., Brizel D.M., Folz R.J., and Vujaskovic Z. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 255-259
6. Taylor J.C., Terrell J.E., Ronis D.L., Fowler K.E., Bishop C., Lambert M.T., Myers L.L., Duffy S.A., Bradford C.R., Chepeha D.B., Hogikyan N.D., Prince M.E., Teknos T.N., and Wolf G.T. University of Michigan Head and Neck Cancer Team, Disability in patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130 (2004) 764-769
7. Vissink A., Jansma J., Spijkervet F.K., Burlage F.R., and Coppes R.P. Oral sequelae of head and neck radiotherapy. Crit. Rev. Oral Biol. Med. 14 (2003) 199-212
8. Vissink A., Burlage F.R., Spijkervet F.K., Jansma J., and Coppes R.P. Prevention and treatment of the consequences of head and neck radiotherapy. Crit. Rev. Oral Biol. Med. 14 (2003) 213-225
9. Nagler R.M., and Baum B.J. Prophylactic treatment reduces the severity of xerostomia following irradiation therapy for oral cavity cancer. Arch. Otolaryngol. Head Neck Surg. 129 (2003) 247-250
10. Ohrn K.E., and Sjoden P.O. Experiences of oral care in patients with haematological malignancies or head and neck cancer. Eur. J. Cancer Care (Engl.) 12 (2003) 274-282
11. Gosselin T.K., and Pavilonis H. Head and neck cancer: managing xerostomia and other treatment induced side effects. ORL Head Neck Nurs. 20 (2002) 15-22
12. Nagler R.M. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis. 8 (2002) 141-146
13. Amerongen A.V., and Veerman E.C. Saliva-The defender of the oral cavity. Oral. Dis. 8 (2002) 12-22
14. Vitolo J.M., and Baum B.J. The use of gene transfer for the protection and repair of salivary glands. Oral. Dis. 8 (2002) 183-191
15. Mastrangeli A., O'Connell B., Aladib W., Fox P.C., Baum B.J., and Crystal R.G. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. J. Physiol. 266 (1994) G1146-G1155
16. Baum B.J., and O'Connell B.C. The impact of gene therapy on dentistry. J. Am. Dent. Assoc. 126 (1995) 179-189
17. Baum B.J., Wellner R.B., and Zheng C. Gene transfer to salivary glands. Int. Rev. Cytol. 213 (2002) 93-146
18. Zufferey R., and Aebischer P. Salivary glands and gene therapy: the mouth waters. Gene Ther. 11 (2004) 1425-1426
19. Baum B.J., Voutetakis A., and Wang J. Salivary glands: novel target sites for gene therapeutics. Trends Mol. Med. 10 (2004) 585-590
20. Delporte C., Redman R.S., and Baum B.J. Relationship between the cellular distribution of the alpha(v), beta3/5 integrins and adenoviral infection in salivary glands. Lab. Invest. 77 (1997) 167-173
21. He X., Kuijpers G.A., Goping G., Kulakusky J.A., Zheng C., Delporte C., Tse C.M., Redman R.S., Donowitz M., Pollard H.B., and Baum B.J. A polarized salivary cell monolayer useful for studying transepithelial fluid movement in vitro. Pflugers Arch. 435 (1998) 375-381
22. Delporte C., O'Connell B.C., He X., Lancaster H.E., O'Connell A.C., Agre P., and Baum B.J. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3268-3273
23. Preston G.M., and Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 11110-11114
24. Delporte C., Hoque A.T., Kulakusky J.A., Braddon V.R., Goldsmith C.M., Wellner R.B., and Baum B.J. Relationship between adenovirus-mediated aquaporin 1 expression and fluid movement across epithelial cells. Biochem. Biophys. Res. Commun. 246 (1998) 584-588
25. Becker T.C., Noel R.J., Coats W.S., Gomez-Foix A.M., Alam T., Gerard R.D., and Newgard C.B. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43A (1994) 161-189
26. O'Connell A.C., Baccaglini L., Fox P.C., O'Connell B.C., Kenshalo D., Oweisy H., Hoque A.T., Sun D., Herscher L.L., Braddon V.R., Delporte C., and Baum B.J. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther. 6 (1999) 505-513
27. Zheng C., Hoque A.T., Braddon V.R., Baum B.J., and O'Connell B.C. Evaluation of salivary gland acinar and ductal cell-specific promoters in vivo with recombinant adenoviral vectors. Hum. Gene Ther. 12 (2001) 2215-2223
28. Li J., Zheng C., Zhang X., Liu X., Zhang C., Goldsmith C.M., Baum B.J., and Wang S. Developing a convenient large animal model for gene transfer to salivary glands in vivo. J. Gene Med. 6 (2004) 55-63
29. Li J., Shan Z., Ou G., Liu X., Zhang C., Baum B.J., and Wang S. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 156-1510
30. Shan Z., Li J., Zheng C., Liu X., Fan Z., Zhang C., Goldsmith C.M., Wellner R.B., Baum B.J., and Wang S. Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. Mol. Ther. 11 (2005) 444-451
31. http://www.fda.gov/ora/compliance_ref/bimo/7348_808/default.htm.
32. Delporte C., Miller G., Kagami H., Lillibridge C.D., O'Connell B.C., Atkinson J.C., and Baum B.J. Safety of salivary gland-administered replication-deficient recombinant adenovirus in rats. J. Oral Pathol. Med. 27 (1998) 34-38
33. O'Connell B.C., Zheng C., Jacobson-Kram D., and Baum B.J. Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats. J. Oral Pathol. Med. 32 (2003) 414-421
34. C. Zheng, A. Voutetakis, M.R. Kok, C.M. Goldsmith, G.B.J. Smith, M. Vallant, R.D. Irwin, B.J. Baum, Toxicity and biodistribution of a first-generation recombinant adenoviral vector, in the presence of hydroxychloroquine, following retroductal delivery to a single rat submandibular gland, Oral Dis. (in press).
35. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211.
36. Adesanya M.R., Redman R.S., Baum B.J., and O'Connell B.C. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 10 (1996) 1085-1093
37. Braddon V.R., Chiorini J.A., Wang S., Kotin R.M., and Baum B.J. Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Hum. Gene Ther. 9 (1998) 2777-2785
38. Harvey B.G., Maroni J., O'Donoghue K.A., Chu K.W., Muscat J.C., Pippo A.L., Wright C.E., Hollmann C., Wisnivesky J.P., Kessler P.D., Rasmussen H.S., Rosengart T.K., and Crystal R.G. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum. Gene Ther. 13 (2002) 15-63
39. Crystal R.G., Harvey B.G., Wisnivesky J.P., O'Donoghue K.A., Chu K.W., Maroni J., Muscat J.C., Pippo A.L., Wright C.E., Kaner R.J., Leopold P.L., Kessler P.D., Rasmussen H.S., Rosengart T.K., and Hollmann C. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum. Gene Ther. 13 (2002) 65-100
40. Sunwoo J.B., Herscher L.L., Kroog G.S., Thomas G.R., Ondrey F.G., Duffey D.C., Solomon B.I., Boss C., Albert P.S., McCullugh L., Rudy S., Muir C., Zhai S., Figg W.D., Cook J.A., Mitchell J.B., and Van Waes C. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J. Clin. Oncol. 19 (2001) 800-811
41. Agre P., Preston G.M., Smith B.L., Jung J.S., Raina S., Moon C., Guggino W.B., and Nielsen S. Aquaporin CHIP: the archetypal molecular water channel. Am. J. Physiol. 265 (1993) F463-F476
42. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., Wilson J.M., and Batshaw M.L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80 (2003) 148-158